EBITDA Margin % is calculated as EBITDA divided by its Revenue. Adiuvo Investments's EBITDA for the
three
months ended in Mar. 2026 was zł-1.05 Mil. Adiuvo Investments's Revenue for the
three
months ended in Mar. 2026 was zł0.05 Mil. Therefore, Adiuvo Investments's EBITDA margin for the quarter that ended in Mar. 2026 was -2,291.30%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Adiuvo Investments EBITDA Margin % Related Terms
Adiuvo Investments EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Adiuvo Investments's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:ADV vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Adiuvo Investments's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adiuvo Investments EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adiuvo Investments's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Adiuvo Investments's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adiuvo Investments (WAR:ADV) has a EBITDA Margin % of -2,291.30% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Adiuvo Investments and its competitors. According to the industry distribution chart, Adiuvo Investments ranks #494 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 60.5%.
Is Adiuvo Investments' EBITDA Margin % too high?
Adiuvo Investments' current EBITDA Margin % is -2,291.30%. Based on the distribution chart, Adiuvo Investments ranks #494 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Adiuvo Investments has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Adiuvo Investments' EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Adiuvo Investments ranks #494 out of 816 companies for EBITDA Margin %. This places Adiuvo Investments in the lower half of its industry. The industry median EBITDA Margin % is 7.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Adiuvo Investments and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adiuvo Investments's current EBITDA Margin % is -2,291.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adiuvo Investments stock overvalued right now?
Based on GuruFocus' analysis, Adiuvo Investments (WAR:ADV) is currently considered Possible Value Trap. The stock's GF Value™ is zł0.88, compared to a current price of zł0.53 — trading 40% below its estimated fair value. The current EBITDA Margin % is -2,291.30%. Adiuvo Investments' overall GF Score™ is 31/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Adiuvo Investments (WAR:ADV), the current EBITDA Margin % is -2,291.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adiuvo Investments (WAR:ADV) Overvalued in 2026?
Based on GuruFocus' analysis, Adiuvo Investments stock appears to be undervalued.
The current stock price of zł0.53 is trading 40% below its estimated GF Value™ of zł0.88.
GuruFocus considers Adiuvo Investments to be Possible Value Trap.
Key valuation signals for WAR:ADV:
EBITDA Margin %: -2,291.30%
GF Value™: zł0.88 vs. price of zł0.53 (40% below fair value)
No single metric tells the full story. See the WAR:ADV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adiuvo Investments SA is engaged in the selection, development, financing and commercialization of projects in the international market. The new technologies developed by the company focus on disease management, monitoring healthy lifestyle and treatment with the help of mobile devices and supplementation and functional food, or food, which in addition to nutritional properties also has health properties.
31GF Score
Get the complete analysis for WAR:ADV
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:ADV has been successfully added to your 
